文献速递神经康复

CORE-10在卒中后急性期患者中的信度、效度与临床实用性

The reliability, validity and clinical utility of the Clinical Outcomes in Routine Evaluation - ten-item version (CORE-10) in post-acute patients with stroke.
PubMed 文献 · Clin Rehabil · 2024-03-05

该研究在英格兰东部卒中后急性期康复病房的53例患者中,评估CORE-10测量心理痛苦的信度、效度与临床实用性。

要点

  • 可靠变化指数9分,临床显著变化切点12分,临床实用性标准达6/6。

核心结论

  • CORE-10是可用于卒中住院患者心理痛苦筛查的有效、可靠且具临床实用性的工具,但证据为初步支持。

研究设计与样本

  • 在英格兰东部卒中后急性期康复病房开展,纳入53例能完成CORE-10的卒中患者,排除中重度失语症和/或失读症者。
  • 同时使用PHQ-9、HADS、CES-D和BDI-II作为同期效标 measure。
  • 计算CORE-10的内部一致性、重测信度(平均间隔2.84天,SD=3.12,Mdn=1)、同期效度及Burton和Tyson(2015)标准的临床实用性。

主要发现

  • CORE-10的Cronbach's α为.80,重测信度组内相关系数为.81。
  • CORE-10总分与同期效标 measure 的相关范围为r=.49至r=.89。
  • CORE-10在临床实用性标准上获得最高分6/6。
  • 计算得出CORE-10的可靠变化指数为9分,临床显著变化切点为12分。

关键数值与推荐

  • CORE-10内部一致性Cronbach's α=.80,重测信度ICC=.81。
  • CORE-10与同期效标总分相关r=.49至r=.89。
  • 临床实用性标准评分6/6。
  • 可靠变化指数为9分,临床显著变化切点为12分。

临床怎么用

  • 可将CORE-10用于卒中住院康复患者心理痛苦的常规筛查。
  • 解读总分变化时,9分及以上可视为可靠变化,12分可作为临床显著变化的切点参考。
  • 对中重度失语症和/或失读症患者,CORE-10的适用性未在本研究中确立。

局限性

  • 样本量仅53例,且来自单一卒中后急性期康复病房,结论为初步支持。
  • 排除了中重度失语症和/或失读症患者,限制了向该人群的外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the validity, reliability, and clinical utility of the Clinical Outcomes in Routine Evaluation - ten-item version (CORE-10: a ten-item questionnaire designed to measure psychological distress) in a stroke inpatient sample and calculate reliable and clinically significant change scores. SETTING: A post-acute stroke rehabilitation ward in the East of England. PARTICIPANTS: A total of 53 patients with stroke, capable of completing the CORE-10 as part of their routine clinical assessment. Exclusion criteria included moderate to severe aphasia and/or alexia. MAIN MEASURES: Alongside the CORE-10, the Patient Health Questionnaire - 9, the Hospital Anxiety and Depression Scale, the Centre for Epidemiological Studies-Depression Scale, and the Beck Depression Inventory Second Edition were used as concurrent measures. RESULTS: To assess reliability, the internal consistency and test-retest reliability of the CORE-10 were calculated. The average number of days between CORE-10 test-retest administrations was 2.84 (SD = 3.12, Mdn = 1). Concurrent validity was assessed by examining correlations between the CORE-10 and comparable measures, and clinical utility was assessed using the criteria of Burton and Tyson (2015). The internal consistency (Cronbach's alpha) for the CORE-10 was .80, and test-retest reliability interclass correlation coefficient was .81. Total score correlations between the CORE-10 and concurrent measures ranged from r = .49 to r = .89. The CORE-10 achieved the maximum score (i.e. 6/6) on criteria for clinical utility. Calculations demonstrated a reliable change index of nine points and a clinically significant change cut point of 12 on the CORE-10. Percentiles for CORE-10 total scores are reported. CONCLUSIONS: This study provides preliminary support for the CORE-10 as a valid and reliable measure that has clinical utility for screening distress in inpatients with stroke.

来源:Clin Rehabil,查看原文。版权归原作者所有。

引用

  1. Steverson T, Marsden J, Blake J, et al. The reliability, validity and clinical utility of the Clinical Outcomes in Routine Evaluation - ten-item version (CORE-10) in post-acute patients with stroke. Clin Rehabil. 2024. PMID: 38439657. doi:10.1177/02692155241236602

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。